Eric L. Keller bought RTSN once, on Oct 13, 2026
Chief Executive Officer at Retension Pharmaceuticals, Inc.
SEC CIK 0002156365 · Filings on SEC.gov ↗
$250KBought
$0Sold
Oct 13Last buy
Eric L. Keller's record
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
1 filing since Oct 2026, newest first
Filings come from SEC EDGAR. Not investment advice.